Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Royal Prima TbkISX:PRIM -1.01%74 Days Payable is 120.37 as of Mar. 2026, which is 64% above its 10-year median of 73.20. GuruFocus rates ISX:PRIM with a GF Score™ of 74/100 and a GF Value™ of Rp81.59 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 607 Healthcare Providers & Services companies, PT Royal Prima Tbk ranks better than 73.48% on this metric.
The historical rank and industry rank for PT Royal Prima Tbk's Days Payable or its related term are showing as below:
ISX:PRIM'
s Days Payable Range Over the Past 10 Years
Min: 36.7 Med: 73.2 Max: 145.73
Current: 114.68
During the past 12 years, PT Royal Prima Tbk's highest Days Payable was 145.73. The lowest was 36.70. And the median was 73.20.
ISX:PRIM's Days Payable is ranked better than 73.48% of 607
companies
in the Healthcare Providers & Services industry
Industry Median: 57.13
vs ISX:PRIM: 114.68
PT Royal Prima Tbk's Days Payable
declined
from Mar. 2025 (139.07) to Mar. 2026 (120.37).
It may suggest that PT Royal Prima Tbkaccelerated paying its suppliers.
PT Royal Prima Tbk Days Payable Related Terms
PT Royal Prima Tbk Days Payable Historical Data
* Premium members only.
The historical data trend for PT Royal Prima Tbk's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ISX:PRIM vs HCA, THC, DVA: Days Payable Comparison
For the Medical Care Facilities subindustry, PT Royal Prima Tbk's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Royal Prima Tbk Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PT Royal Prima Tbk's Days Payable distribution charts can be found below:
* The bar in red indicates where PT Royal Prima Tbk's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
PT Royal Prima Tbk's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Royal Prima Tbk (ISX:PRIM) has a Days Payable of 120.37 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on PT Royal Prima Tbk and its competitors. This is 64% above median its historical median of 73.20. Over the past decade, PT Royal Prima Tbk's Days Payable has ranged from 36.70 to 145.73. According to the industry distribution chart, PT Royal Prima Tbk ranks #161 out of 607 companies in the Healthcare Providers & Services industry, placing it in the top 26.5%.
Is PT Royal Prima Tbk's Days Payable too high?
PT Royal Prima Tbk's current Days Payable of 120.37 is 64% above median its 10-year median of 73.20. Over the past 10 years, this metric has ranged from a low of 36.70 to a high of 145.73. The Healthcare Providers & Services industry median Days Payable is 57.13. PT Royal Prima Tbk's value of 120.37 is 110.7% above this industry median. Based on the distribution chart, PT Royal Prima Tbk ranks #161 out of 607 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, PT Royal Prima Tbk has a GF Score™ of 74/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PT Royal Prima Tbk's Days Payable compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PT Royal Prima Tbk ranks #161 out of 607 companies for Days Payable. This puts PT Royal Prima Tbk in the upper half of its industry. The industry median Days Payable is 57.13. PT Royal Prima Tbk's value of 120.37 is 110.7% above this benchmark. Historically, PT Royal Prima Tbk's own Days Payable has ranged from 36.70 to 145.73 over the past decade. While the company's 10-year median is 73.20 vs. the industry median of 57.13, PT Royal Prima Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 57.13, based on 607 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Royal Prima Tbk's current Days Payable of 120.37 is 110.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on PT Royal Prima Tbk and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 57.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Royal Prima Tbk's current Days Payable is 120.37, which is 64% above median its own 10-year median of 73.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Royal Prima Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Royal Prima Tbk (ISX:PRIM) is currently considered Modestly Overvalued. The stock's GF Value™ is Rp81.59, compared to a current price of Rp98.00 — trading 20.1% above its estimated fair value. The current Days Payable is 120.37, which is 64% above median its 10-year median of 73.20 and 110.7% above the Healthcare Providers & Services industry median of 57.13. PT Royal Prima Tbk's overall GF Score™ is 74/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For PT Royal Prima Tbk (ISX:PRIM), the current Days Payable is 120.37 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Royal Prima Tbk (ISX:PRIM) Overvalued in 2026?
Based on GuruFocus' analysis, PT Royal Prima Tbk stock appears to be overvalued.
The current stock price of Rp98.00 is trading 20.1% above its estimated GF Value™ of Rp81.59.
GuruFocus considers PT Royal Prima Tbk to be Modestly Overvalued.
Key valuation signals for ISX:PRIM:
Days Payable: 120.37 (64% above median its 10-year median of 73.20)
GF Value™: Rp81.59 vs. price of Rp98.00 (20.1% above fair value)
Industry Position: 110.7% above the Healthcare Providers & Services median (#161 of 607)
No single metric tells the full story. See the ISX:PRIM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Royal Prima Tbk is engaged in health services which consist of the provision of hospital services, polyclinics, hall treatment, maternity hospital, and specialist hospital. It has three geographic segments: RSU Royal Prima, RS Royal Prima Jambi, and Rumah Sakit Marelan. The company generates the majority of its revenue from RSU Royal Prima segment. The company generates revenue from Drugs and medical supplies, doctors' and nurses' fees, Hospital facilities, Room services, and Others.
74GF Score
Get the complete analysis for ISX:PRIM
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:PRIM has been successfully added to your 
